# Perineural Versus IV Dexmedetomidine as Adjuvant to Quadratus Lamborum Block for Pediatrics Undergoing Pyeloplasty

> **NCT03885804** · EARLY_PHASE1 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 50 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Quadratus lamborum dexmedetomidine intravenous
- **DRUG:** Quadratus lamborum dexmedetomidine perineural group(

## Key facts

- **NCT ID:** NCT03885804
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-20
- **Primary completion:** 2019-07-10
- **Final completion:** 2019-08-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03885804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03885804, "Perineural Versus IV Dexmedetomidine as Adjuvant to Quadratus Lamborum Block for Pediatrics Undergoing Pyeloplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03885804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*